In a nutshell This study investigated the effect of cetuximab (Erbitux) in patients with metastatic (spread to other parts of the body) colorectal cancer who did not respond to initial cetuximab treatment. Researchers suggested that this treatment may be beneficial in longer treatment durations. Some background The standard treatment for patients...
Read More
In a nutshell This study investigated the effectiveness of the chemotherapy FOLFOX plus cetuximab (Erbitux), after cancer progression with FOLFIRI plus cetuximab. Researchers suggested that FOLFOX plus cetuximab is an important treatment option in non-KRAS mutated metastatic (spread to other parts of the body) colorectal cancer. Some background...
Read More
In a nutshell This meta-analysis examined the risk of fatal adverse events among various advanced cancer patients receiving EGFR-targeting monoclonal antibodies. Some background A mutation causing the overproduction (termed overexpression) of epidermal growth factor receptor (EGFR), which plays a role in the creation, migration, and survival of...
Read More
